Global Wellness’ Shanti Therapeutics Submits Human Research Ethics Committee (HREC) Application
Shanti Therapeutics, a subsidiary of Global Wellness (GWS), is awaiting ethics committee approval to conduct one of the first studies on MDMA for pain management.